Memento MedicaHistory of medicine & the mind
All stories

Minamata disease, methylmercury poisoning & corporate evidence · Minamata, Japan, 1956–1968

Hajime Hosokawa and Cat 400

A company doctor reproduced the strange neurological illness seen around Minamata Bay. The experiment pointed back toward the factory that employed him—and then stopped.

6 minute read · 1,276 words · Published November 16, 2026

An anonymous company physician studies an observation card in a 1950s laboratory overlooking a bay and chemical plant.
AI conceptual illustration of a company-hospital experiment in 1959 Minamata. It is not Hajime Hosokawa, cat 400, or a documented laboratory.

Content note: Industrial poisoning, neurological disability, animal experimentation, community illness and death, and suppression of evidence; no graphic imagery.

The observation card belonged to a cat numbered 400. What happens when an experiment points back to the factory paying for it?

In 1956, doctors in Minamata, Japan, reported an unfamiliar neurological illness among residents who depended on fish and shellfish from the bay. Children and adults developed numbness, loss of coordination, visual and hearing changes, and severe neurological impairment. Cats and birds also behaved strangely.

Hajime Hosokawa directed the hospital operated by the Chisso chemical company. His position gave him access to patients and to the industrial process under suspicion. In 1959, a company-hospital experiment fed cats food mixed with wastewater from acetaldehyde production. Cat 400 developed symptoms.

The experiment did not end uncertainty by itself, and animal evidence was not the only line of investigation. Yet it connected factory effluent to a recognizable syndrome at a moment when delay meant continued exposure. The work was halted and the result was not promptly made public.

A disease carried through ordinary food

Minamata’s fishing households did not encounter mercury as a labeled chemical. Exposure arrived through familiar meals. Methylmercury released in industrial wastewater accumulated in fish and shellfish, moving through the food chain into people who relied on the bay.

The first officially recognized patient was reported in May 1956. Families had already noticed sick children, affected adults, and animals with alarming neurological signs. The pattern was local enough to provoke suspicion and diffuse enough to resist quick proof.

Kumamoto University investigators concluded in November 1956 that contaminated seafood and a heavy metal were likely involved. Identifying the precise substance and industrial route took longer. Competing hypotheses, incomplete chemical techniques, economic dependence on Chisso, and institutional hesitation all shaped the pace.

The community’s predicament was immediate. Avoiding fish threatened food and livelihood; continuing to eat it risked exposure. Government authorities did not promptly impose a fishing ban, while wastewater continued to enter the environment.

Sources [1] · [2] · [3] · [5]

The hospital inside the company

Hosokawa occupied an ethically divided position. As a physician, he treated people with a devastating disease. As director of Chisso’s hospital, he worked within the company whose factory processes were increasingly suspected.

Company hospitals can create valuable access to occupational and community illness. They can also place medical evidence inside an organization with financial and legal reasons to control it. The Minamata investigation made that conflict unusually stark.

Researchers had already fed cats fish and shellfish from the bay, reproducing illness and strengthening the food-chain hypothesis. Chisso’s internal experiments addressed a narrower question: could wastewater from the acetaldehyde process reproduce the syndrome?

In July 1959, Hosokawa began experiments that mixed process effluent into cat food. On October 6, cat 400 developed symptoms. Official historical accounts record that the experiment was then stopped on company instruction.

Sources [1] · [2] · [4] · [6]

What one animal could and could not prove

Cat 400 did not, alone, establish every link in the causal chain. An animal experiment requires controls, reproducibility, chemical characterization, pathology, and comparison with human disease. The surviving record is also filtered through later investigations and institutional accounts.

But the experiment mattered because of convergence. Residents’ geography, seafood exposure, clinical findings, environmental sampling, university studies, and company-process evidence were pointing in the same direction. The cat result was not isolated from that map.

Later examination of specimens from other historic Chisso cat experiments found central-nervous-system lesions and elevated mercury consistent with methylmercury poisoning. That retrospective work strengthened the interpretation without erasing the uncertainty and secrecy surrounding the original program.

The evidence should be described precisely: wastewater from the acetaldehyde process produced a Minamata-like syndrome in experimental cats. It supported the factory-effluent hypothesis; it was not the sole discovery of methylmercury’s role.

Sources [1] · [2] · [4]

Delay as a medical event

When evidence is withheld during ongoing exposure, delay becomes more than an administrative failure. It changes who remains at risk and how long exposure continues.

By 1959, Kumamoto University’s group had publicly argued for organic mercury. Government bodies also recognized organic mercury as the likely cause. Chisso disputed the theory and did not publish the cat result. The factory continued operations while communities sought recognition and relief.

The company installed treatment equipment, but official histories explain that it did not remove the causative methylmercury from the relevant wastewater. Changing discharge routes could move contamination rather than end it.

These decisions demonstrate why causal evidence cannot be separated from authority. Researchers may identify a hazard, yet prevention depends on who can stop production, warn residents, compensate families, and preserve inconvenient records.

Sources [1] · [2] · [3] · [5] · [6]

The body records a food chain

Methylmercury is readily absorbed and damages the nervous system. In Minamata, the clinical pattern included sensory disturbance, impaired coordination, constricted visual fields, hearing and speech difficulties, and severe disability. Prenatal exposure caused profound effects in children whose mothers could appear less severely affected.

The mechanism connected factory chemistry to household meals. Mercury used in acetaldehyde production generated methylmercury as a by-product. Discharged into water, it accumulated in aquatic life and became concentrated through repeated consumption.

That pathway explains why clear-looking water or normal-looking fish could not reassure residents. The contamination did not need to announce itself through color, smell, or visible decay.

It also complicates the language of individual choice. People ate foods central to local culture and economy, without access to the industrial information needed to assess risk.

Sources [2] · [3] · [5]

Recognition after the exposure

In 1968, the Japanese government announced its consensus that Minamata disease was caused by methylmercury from industrial wastewater that accumulated in fish and shellfish. By then, acetaldehyde production at the Minamata plant had ended.

Legal judgments and compensation systems followed years of struggle. Certification rules, unsettled claims, environmental remediation, and disputes over the boundaries of injury continued long after official causation was accepted.

The history therefore has no clean ending in a single announcement. Recognition can validate evidence while leaving families to contest eligibility, disability, and responsibility.

Hosokawa later testified about the cat experiment. His role should not be simplified into either silent company servant or solitary whistleblower. The record shows a physician who produced crucial internal evidence within constraints and did not make it public when it could have mattered most.

Sources [2] · [3] · [5] · [6]

Evidence after recognition

Official recognition did not make the evidence politically neutral. Medical certification determined access to compensation, and narrow diagnostic criteria could exclude people with real exposure and symptoms. Researchers and courts continued to revisit what counted as Minamata disease, who bore responsibility, and how uncertainty should be handled when records were incomplete.

This later history reinforces the lesson of 1959. Evidence is not only a laboratory result; it becomes consequential through rules about disclosure, warning, eligibility, and remedy. The preserved cat specimens mattered scientifically, while the preserved testimony of residents mattered socially and legally. Both challenged institutions that preferred a smaller, later, and more containable account of harm.

The disease also produced a vocabulary of stigma. Affected families could face discrimination in marriage, work, and community life. Recognition therefore carried a double burden: people needed the diagnosis to obtain help, yet the label could expose them to rejection. That tension belongs inside the medical history because it shaped who came forward and how damage was counted.

Sources [2] · [4] · [5] · [6]

The card on the laboratory table

Cat 400 became memorable because a number can make suppressed evidence concrete. It marks a living experiment, an observed change, and a decision about whether information would travel beyond a company wall.

The larger proof of Minamata disease came from many sources: affected families, fishermen, clinicians, university researchers, pathologists, chemists, government inquiries, courts, and preserved specimens. No single observer owned the discovery.

The psychological tension lies in knowing before an institution is willing to act. Evidence can be technically incomplete and still urgent enough to justify stopping exposure. Waiting for perfect certainty may protect the process producing harm.

The numbered card therefore represents two experiments. One tested wastewater in an animal. The other, conducted without consent across a community, tested how long industry and government could delay the meaning of what people were already living through.

Sources [1] · [2] · [3] · [4] · [6]

More stories from Memento Medica

For more interesting content, follow Memento Medica on YouTube.

Follow Memento Medica

Written and illustrated with AI assistance for Memento Medica. The lead image is a conceptual reconstruction, not a historical photograph, a likeness of Hajime Hosokawa, or a documented laboratory. Factual claims were checked against the references listed below.

Sources & what we can know

This original account does not invent dialogue, patient identities, or Hosokawa’s private thoughts. It distinguishes the cat experiment from the broader causal record and avoids a sole-discoverer or simple-whistleblower claim. Follow @MementoMedicaOfficial for more independently sourced stories from the history of medicine.

  1. National Institute for Minamata Disease: Determination of the Cause

    Official historical chronology used for discovery, research hypotheses, cat experiments, company response, and continued discharge.

  2. Ministry of the Environment: Minamata Disease—History and Measures

    Government synthesis used for methylmercury mechanism, exposure pathway, official recognition, and policy chronology.

  3. National Institute for Minamata Disease: Mercury Q&A

    Current institutional explanation of effluent, food-chain accumulation, and human exposure.

  4. Tohoku Journal of Experimental Medicine: Reappraisal of the Historic 1959 Cat Experiment

    Peer-reviewed retrospective analysis of preserved cat-experiment specimens; used for pathology and evidentiary limits.

  5. Supreme Court of Japan: Minamata Disease Judgment

    Official judicial summary used for the 1959 scientific and administrative chronology and nonpublication of the factory experiment.

  6. National Institute for Minamata Disease: Social Scientific Study Report

    Official historical report used for Hosokawa, cat 400, experimental cessation, and later causal research.